Cyberonics’ VNS Therapy Approvable As Last-Resort Depression Fix – Panel
This article was originally published in The Gray Sheet
Executive Summary
FDA's Neurological Devices Panel set aside its desire for an additional, randomized trial of Cyberonics' VNS Therapy depression indication at a June 15 meeting to review the device in Gaithersburg, Md